Biologic Therapies Summit X and Vasculitis online series
Optimizing outcomes in IMIDs: Focus on Co-Morbidities
Release date: July 13, 2023
Expiration date: July 12, 2025
Estimated Time of Completion: 1 hour and 30 minutes
Session Agenda:
ILD across IMIDs
Joseph Parambil, MD, Cleveland Clinic
Assessing and treating cardiovascular risk in immune-mediated diseases
Pulkit Chaudhury, MD, Cleveland Clinic
Clinical approach to IBD and immune-mediated diseases
Florian Rieder, MD, Cleveland Clinic
Description
Watch Biologic Therapies Summit X and Vasculitis Online Series, on-demand, complimentary webcasts that brings together world leaders in immune-based therapies to address cutting-edge topics in immunology and rheumatology. Education focuses on vasculitis, including key issues in the differential diagnosis of vasculitis, CNS vasculitis, ANCA-associated vasculitis, and organ-specific issues in vasculitis. In addition, the online series features talks on CAR T-cell therapy, irAEs, precision medicine and the next generation of JAK inhibitors for IMIDs, and advances in complement biology and therapy. A deep dive into rheumatoid arthritis, AS, PsA and SpA, infections, COVID-19, co-morbidities with IMIDs, including ILD and cardiovascular risk in immune-mediated diseases, and lupus. Lastly, the CE-certified webcasts address pain management and the exploration of the social and scientific fundamentals of pain.
Disclosures
Cassandra Calabrese, DO | |
Astra Zeneca, Lilly |
Consulting |
Sanofi-Regeneron |
Consulting |
Leonard Calabrese, DO | |
Astra Zeneca, BMS |
Teaching and Speaking |
Novartis, Regeneron, Sanofi Aventis |
Consulting |
Genentech/Roche |
Consulting |
Abbvie Pharmaceuticals, Janssen, UCB |
Consulting |
M. Elaine Husni, MD, MPH | |
Abbvie Pharmaceuticals, Amgen, Bristol-Myers Squibb Co, Genzyme/Sanofi, Janssen, Lilly, Regeneron |
Consulting |
Celgene Corporation, Pfizer, Inc. |
Advisor or review panel participant |
Genenetch, UCB, Inc. |
Consulting |
Novartis Pharmaceuticals |
Consulting |
WebMD |
Consulting |
Elizabeth Kirchner, DNP | |
Janssen Pharmaceuticals, Inc. |
Consulting |
RhAPP |
Teaching and Speaking |
Boehringer Ingelheim, Horizon Pharma, UCB |
Advisor or review panel participant |
Carol Langford, MD | |
Astrazeneca Pharmaceuticals |
Other activities from which remuneration is received or expected: Non-paid consultant for research Clinical trial funding support - this has ended |
Bristol-Myers Squibb Co. |
Other activities from which remuneration is received or expected: Clinical trial funding support Non- paid consultant for research |
Chemocentryx, GlaxoSmithKline |
Other activities from which remuneration is received or expected: Clinical trial funding support |
Abbvie Pharmaceuticals |
Other activities from which remuneration is received or expected: Non- paid consultant for research |
Amanda Mixon, PA-C | |
Abbvie Pharmaceuticals |
Consulting |
Eli Lilly, Janssen Pharmaceuticals, Inc |
Advisor or review panel participant |
Amgen |
Teaching and Speaking |
Astrazeneca Pharmaceuticals, RhAPP, Sanofi |
Advisor or review panel participant |
UCB, Inc. |
Consulting |
Florian Rieder, MD | |
Abbvie Pharmaceuticals, Boehringer Ingelheim, Celgene Corporation, Helmsley, Pliant, RedX, Roche Pharmaceuticals, Thetis |
Consulting |
The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
Pulkit Chaudhury, MD
Joseph Parambil, MD
Acknowledgment
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this live activity from:
AbbVie, Inc.
Amgen, Inc.
AstraZeneca Pharmaceuticals
Bristol Myers Squibb
Genentech
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
Pfizer, Inc.
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this enduring activity from:
AbbVie, Inc.
Amgen, Inc.
AstraZeneca Pharmaceuticals
Bristol Myers Squibb
Genentech
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education, Cleveland Clinic’s R.J Fasenmyer Center for Clinical Immunology.